Status:
COMPLETED
Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
University of Chicago
Dana-Farber Cancer Institute
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to study patients presenting with stage IV breast cancer. Stage IV means that the breast cancer has spread to another part of the body outside the breast. This study is im...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Known or suspected Stage IV breast cancer with intact primary tumor
- Known or suspected Stage IV breast cancer with intact primary tumor, having begun systemic therapy within the past 12 months
- Known or suspected Stage IV breast cancer within 3 months of local breast surgery
- Known or suspected Stage IV breast cancer within 3 months of local breast surgery, having begun systemic therapy within the past 12 months
Exclusion
- Primary breast cancer diagnosis made by FNA only and no pre-treatment core biopsy planned for diagnostic or research purposes.
- Failure of MSKCC or participating site to confirm Stage IV breast cancer diagnosis by biopsy within 30 days of study enrollment
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 10 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00941759
Start Date
July 1 2009
End Date
July 10 2023
Last Update
July 16 2025
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
2
University of California San Francisco
San Francisco, California, United States, 94143
3
Georgetown University
Washington D.C., District of Columbia, United States
4
Washington Cancer Institute at Washington
Washington D.C., District of Columbia, United States